S. Ubol

A. Nishizono, I. Kurane, Y. Shoji, 2006, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

Humoral and cell-mediated immune responses to various economical regimens of purified Vero cell rabies vaccine.

S. Sirivichayakul, P. Phanuphak, S. Ubol, 1987, Asian Pacific journal of allergy and immunology.

Inducible nitric oxide synthase inhibition delays death of rabies virus-infected mice.

S. Ubol, Y. Maneerat, C. Sukwattanapan, 2001, Journal of medical microbiology.

A novel rapid fluorescent focus inhibition test for rabies virus using a recombinant rabies virus visualizing a green fluorescent protein.

A. Nishizono, I. Kurane, Y. Shoji, 2005, Journal of virological methods.

Intranasal Administration of RBD Nanoparticles Confers Induction of Mucosal and Systemic Immunity against SARS-CoV-2

S. Ubol, P. Sunintaboon, R. Chawengkirttikul, 2021, Vaccines.

Cell-mediated immune response following intracutaneous immunisation with human diploid cell rabies vaccine.

P. Phanuphak, S. Ubol, B. Sriwanthana, 1985, Asian Pacific journal of allergy and immunology.

Dengue: An Emerging Health Challenge ?

S. Ubol, 2017 .

Intrinsic antibody-dependent enhancement of microbial infection in macrophages: disease regulation by immune complexes

Suresh Mahalingam, S. Halstead, D. Mosser, 2010, The Lancet Infectious Diseases.

TNF-alpha induces caspase 3 (CPP 32) dependent apoptosis in human cholangiocarcinoma cell line.

S. Ubol, N. Tangthawornchaikul, S. Sirisinha, 2000, The Southeast Asian journal of tropical medicine and public health.

Proteomic analysis of CHIKV‐infected human fibroblast‐like synoviocytes: Identification of host factors potentially associated with CHIKV replication and cellular pathogenesis

Duncan R. Smith, S. Roytrakul, S. Ubol, 2020, Microbiology and immunology.

A novel dengue virus serotype-2 nanovaccine induces robust humoral and cell-mediated immunity in mice.

R. Jarman, I. Yoon, S. Ubol, 2015, Vaccine.

Subversion of Innate Defenses by the Interplay between DENV and Pre-Existing Enhancing Antibodies: TLRs Signaling Collapse

S. Kalayanarooj, S. Ubol, N. Modhiran, 2010, PLoS neglected tropical diseases.

Ubiquitin‐Conjugating Enzyme E2 L3 is Downregulated by the Chikungunya Virus nsP2 Protease

D. Kovanich, P. Auewarakul, C. Saisawang, 2018, Proteomics. Clinical applications.

High concentrations of circulating interleukin‐6 and monocyte chemotactic protein‐1 with low concentrations of interleukin‐8 were associated with severe chikungunya fever during the 2009–2010 outbreak in Thailand

S. Ubol, W. Phuklia, Montri Thannagith, 2012, Microbiology and immunology.

Dengue virus (DENV) antibody-dependent enhancement of infection upregulates the production of anti-inflammatory cytokines, but suppresses anti-DENV free radical and pro-inflammatory cytokine production, in THP-1 cells.

S. Kalayanarooj, S. Ubol, Siripen Kalayanarooj, 2007, The Journal of general virology.

Involvement of ATP synthase β subunit in chikungunya virus entry into insect cells

C. Thepparit, Atichat Kuadkitkan, Duncan R. Smith, 2014, Archives of Virology.

Partial construction of apoptotic pathway in PBMC obtained from active SLE patients and the significance of plasma TNF-α on this pathway

S. Ubol, S. Kantachuvesiri, Y. Kitiyanant, 2006, Clinical Rheumatology.

The synergistic effect of nsP2-L618, nsP3-R117, and E2-K187 on the large plaque phenotype of chikungunya virus

S. Yoksan, S. Ubol, R. Pulmanausahakul, 2018, Virus Genes.

A bivalent form of nanoparticle-based dengue vaccine stimulated responses that potently eliminate both DENV-2 particles and DENV-2-infected cells.

S. Ubol, P. Sunintaboon, Jitra Limthongkul, 2023, Vaccine.

Small plaque size variant of chikungunya primary isolate showed reduced virulence in mice.

S. Yoksan, S. Ubol, R. Pulmanausahakul, 2018, Asian Pacific journal of allergy and immunology.

Flow cytometric detection of intracellular cytokines in peripheral blood of HIV-1 infected Thai children.

S. Nitayaphan, S. Ubol, S. Akapirat, 2001, Asian Pacific journal of allergy and immunology.

Antibody to peptides of human myelin basic protein in post-rabies vaccine endophalomyelitis sera

D. Griffin, S. Ubol, T. Hemachudha, 1990, Journal of Neuroimmunology.

Chikungunya nsP2 protease is not a papain-like cysteine protease and the catalytic dyad cysteine is interchangeable with a proximal serine

C. Saisawang, Duncan R. Smith, A. Ketterman, 2015, Scientific Reports.

Proteomic Analysis of Chikungunya Virus Infected Microgial Cells

P. Auewarakul, Duncan R. Smith, Nitwara Wikan, 2012, PloS one.

Anti-HIV positivity in Thailand: the usefulness of another ELISA test kit and Western blot as confirmatory tests.

P. Phanuphak, S. Ubol, A. Traisupa, 1987, Asian Pacific Journal of Allergy and Immunology.

Involvement of ATP synthase β subunit in chikungunya virus entry into insect cells

C. Thepparit, Atichat Kuadkitkan, Duncan R. Smith, 2014, Archives of Virology.

Dengue virus infection of erythroid precursor cells is modulated by both thalassemia trait status and virus adaptation.

S. Yoksan, S. Fucharoen, Duncan R. Smith, 2014, Virology.

Novel Potent Autophagy Inhibitor Ka-003 Inhibits Dengue Virus Replication

S. Borwornpinyo, S. Ubol, A. Tubsuwan, 2023, Viruses.

A Field-Deployable Reverse Transcription Recombinase Polymerase Amplification Assay for Rapid Detection of the Chikungunya Virus

P. Patel, F. Hufert, A. Abd El Wahed, 2016, PLoS neglected tropical diseases.

Intranasal immunization with the bivalent SARS-CoV-2 vaccine effectively protects mice from nasal infection and completely inhibits disease development.

W. Wiriyarat, S. Ubol, P. Sunintaboon, 2024, Vaccine.

Attenuating characteristics of DEN-2 PDK53 in flavivirus-naïve peripheral blood mononuclear cells.

R. Kinney, S. Ubol, J. Kasisith, 2007, Vaccine.

Responses of primary human nasal epithelial cells to EDIII-DENV stimulation: the first step to intranasal dengue vaccination

S. Ubol, P. Sunintaboon, Nattika Nantachit, 2016, Virology Journal.